Modifiable Risk Factors Associated with Moyamoya Disease: A Case-Control Study

Conditions

Moyamoya disease

Yu X, Ge P, Zhai Y, Liu W, Zhang Q, Ye X, Liu X, Wang R, Zhang Y, Zhao J, Zhang D.

2023-09-302 citations

10.1007/s00701-023-05816-y

Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Li J, Ge P, Zhang Q, Lin F, Wang R, Zhang Y, Zhang D, Wang W, Zhao J.

2021-01-2712 citations

10.1007/s10143-021-01482-9

Modifiable Risk Factors Associated With Moyamoya Disease

Peicong Ge, Qian Zhang, Xun Ye, Xingju Liu, Xiaofeng Deng et al. (10 authors)

Stroke2020-07-0961 citations

10.1161/strokeaha.120.030027

Papers published before 2002-11-01 may not appear yet. Historical indexing is in progress.

Interventions

Patients with moyamoya disease:N/A

healthy control individuals:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. has been diagnosed with moaymoya disease (using the MRA/DSA); 2. signed the informed consent.

Exclusion criteria

Exclusion criteria: patients with coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame
Heat rate;Systolic blood pressure;diastolic blood pressure;Body mass index;triglyceride;total cholesterol;high-density lipoprotein (HDL) cholesterol;low-density lipoprotein (LDL) cholesterol;apolipoprotein A;apolipoprotein B;homocysteine;	—

Secondary

Measure	Time frame
white blood cell count;lymphocyte count;platelet count;glucose;albumin;creatinine;uric acid;	—

Countries

China

Contacts

Public ContactQian Zhang

Beijing Tiantan Hospital, Capital Medical University

zhangqianchina@yahoo.com+86 13611075005

Outcome results

None listed